Key clinical point: Poor sleep and sleep disorders are prevalent in patients with mild to moderately severe multiple sclerosis (MS) and are associated with other comorbidities.
Main finding: Poor sleep was reported in 66% of patients with MS, sleep apnea in 31%, insomnia in 29%, and restless legs in 26%. Poor sleep and insomnia were independent predictors of fatigue (odds ratio, 2.63; P = .046) and depression (odds ratio, 5.62; P = .003), respectively.
Study details: A sleep substudy of a randomized controlled trial, including 111 adults with MS and an expanded disability status scale score between 2 and 6.
Disclosures: The study was supported by a grant from the National Health and Medical Research Council-Motor Impairment Program.
Citation: Hensen HA, et al. Sleep Med. 2019 Dec 16. doi: 10.1016/j.sleep.2019.11.415.